James E. Flynn - *Possible Member of 10% Group, 10%+ Owner at Singular Genomics Systems, Inc.

Issuer-level insider activity

Role: *Possible Member of 10% Group, 10%+ Owner
Issuer ticker: OMIC
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by James E. Flynn since 14 Sep 2025

Reported holdings for James E. Flynn in Singular Genomics Systems, Inc.

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: Common Stock
Shares / value: 7,484,871
Estimated value: $3,169,094
Report date: 01 Jun 2021
Price: $0.4234
Ownership: Through Deerfield Private Design Fund IV, L.P.

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: Common Stock
Shares / value: 1,627,148
Estimated value: $688,934
Report date: 01 Jun 2021
Price: $0.4234
Ownership: Through Deerfield Partners, L.P.

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 30,000
Estimated value: $33,000
Report date: 01 Jun 2021
Price: $1.10
Ownership: Through Deerfield Management Company, L.P.
Underlying class: Common Stock
Underlying amount: 30,000

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: 6% Convertible Note due 2023
Shares / value: 0
Estimated value
Report date: 01 Jun 2021
Price
Ownership: Through Deerfield Partners, L.P.
Underlying class: Common Stock
Underlying amount

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: 6% Convertible Note due 2023
Shares / value: 0
Estimated value
Report date: 01 Jun 2021
Price
Ownership: Through Deerfield Private Design Fund IV, L.P.
Underlying class: Common Stock
Underlying amount

Form 4 holding *Possible Member of 10% Group, 10%+ Owner

Singular Genomics Systems, Inc.

Security class: Series B Preferred Stock
Shares / value: 0
Estimated value
Report date: 01 Jun 2021
Price
Ownership: Through Deerfield Private Design Fund IV, L.P.
Underlying class: Common Stock
Underlying amount

Transaction history for James E. Flynn in Singular Genomics Systems, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .